Clinical outcomes and prognosis of recurrent thymoma management

Journal of Thoracic Oncology

Volumn 7, Issue 8, 2012, Pages 1304-1314

  Bae, Mi Kyung ^a   Byun, Chun Sung ^a   Lee, Chang Young ^a   Lee, Jin Gu ^a   Park, In Kyu ^b   Kim, Dae Joon ^a   Yang, Woo Ick ^a   Chung, Kyung Young ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Seoul National University Hospital   (South Korea)

Author keywords

Management; Outcomes; Recurrence; Thymoma

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; IFOSFAMIDE; VINCRISTINE;

ADJUVANT CHEMORADIOTHERAPY; ADULT; AGED; ARTICLE; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL FEATURE; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; REOPERATION; RETROSPECTIVE STUDY; THYMOMA; TUMOR RECURRENCE; WORLD HEALTH ORGANIZATION;

EID: 84863815870     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e3182598a91     Document Type: Article

References (24)

1. Gadalla SM, Rajan A, Pfeiffer R, et al. A population-based assessment of mortality and morbidity patterns among patients with thymoma. Int J Cancer 2011;128:2688-2694.
2. Detterbeck FC, Parsons AM. Management of stage I and II thymoma. Thorac Surg Clin 2011;21:59-67, vi.
3. Lucchi M, Mussi A. Surgical treatment of recurrent thymomas. J Thorac Oncol 2010;5(10 Suppl 4):S348-S351.
4. Ciccone AM, Rendina EA. Treatment of recurrent thymic tumors. Semin Thorac Cardiovasc Surg 2005;17:27-31.
5. Regnard JF, Zinzindohoue F, Magdeleinat P, Guibert L, Spaggiari L, Levasseur P. Results of re-resection for recurrent thymomas. Ann Thorac Surg 1997;64:1593-1598.
6. Ruffini E, Mancuso M, Oliaro A, et al. Recurrence of thymoma analysis of clinicopathologic features, treatment, and outcome. J Thorac Cardiovasc Surg 1997;113:55-63.
7. Haniuda M, Kondo R, Numanami H, Makiuchi A, Machida E, Amano J. Recurrence of thymoma clinicopathological features, re-operation, and outcome. J Surg Oncol 2001;78:183-188.
8. Margaritora S, Cesario A, Cusumano G, et al. Single-centre 40-year results of redo operation for recurrent thymomas. Eur J Cardiothorac Surg 2011;40:894-900.
9. Girard N, Mornex F, Van Houtte P, Cordier JF, van Schil P. Thymoma: a focus on current therapeutic management. J Thorac Oncol 2009;4: 119-126.
10. Falkson CB, Bezjak A, Darling G, et al. Lung Cancer Disease Site Group of Cancer Care Ontarios Program in Evidence-Based Care. The management of thymoma: a systematic review and practice guideline. J Thorac Oncol 2009;4:911-919.
11. Fujii Y. Published guidelines for management of thymoma. Thorac Surg Clin 2011;21:125-9, viii.
12. Huang J, Detterbeck FC, Wang Z, Loehrer PJ Sr. Standard outcome measures for thymic malignancies. J Thorac Oncol 2010;5:2017-2023.
13. Rosai J, Sobin LH. Histological typing of tumors of the thymus. In: WHO International Histological Classification of Tumors, 2nd ed. New York, NY:Spinger Verlag, 1999.
14. Strbel P, Bauer A, Puppe B, et al. Tumor recurrence and survival in patients treated for thymomas and thymic squamous cell carcinomas: a retrospective analysis. J Clin Oncol 2004;22:1501-1509.
15. Suster S, Moran CA. Primary thymic epithelial neoplasms showing combined features of thymoma and thymic carcinoma. A clinicopathologic study of 22 cases. Am J Surg Pathol 1996;20:1469-1480.
16. Masaoka A, Monden Y, Nakahara K, Tanioka T. Follow-up study of thymomas with special reference to their clinical stages. Cancer 1981; 48:2485-2492.
17. National Cancer Institute. Common Terminology Criteria for Adverse Events 4.0 (CTCAE). Available at: http://ctep.cancer.gov/protocolDevelopment/ electronic-applications/ctc.htm. Accessed January, 2012.
18. Kirschner PA. Reoperation for thymoma: report of 23 cases. Ann Thorac Surg 1990;49:550-554; discussion 555.
19. Blumberg D, Port JL, Weksler B, et al. Thymoma: a multivariate analysis of factors predicting survival. Ann Thorac Surg 1995;60:908-913; discussion 914.
20. Okumura M, Shiono H, Inoue M, et al. Outcome of surgical treatment for recurrent thymic epithelial tumors with reference to world health organization histologic classification system. J Surg Oncol 2007;95:40-44.
21. Lucchi M, Davini F, Ricciardi R, et al. Management of pleural recurrence after curative resection of thymoma. J Thorac Cardiovasc Surg 2009;137:1185-1189.
22. Verley JM, Hollmann KH. Thymoma. A comparative study of clinical stages, histologic features, and survival in 200 cases. Cancer 1985;55:1074-1086.
23. Pescarmona E, Rendina EA, Venuta F, Ricci C, Baroni CD. Recurrent thymoma: evidence for histological progression. Histopathology 1995;27:445-449.
24. Tateyama H, Takahashi E, Saito Y, et al. Histopathologic changes of thymoma preoperatively treated with corticosteroids. Virchows Arch 2001;438:238-247.